Trademark Overview
On Thursday, September 19, 2024, a trademark application was filed for PAIRXBIO with the United States Patent and Trademark Office. The USPTO has given the PAIRXBIO trademark a serial number of 98759496. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, March 17, 2025. This trademark is owned by PairX Bio Pte. Ltd.. The PAIRXBIO trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Biological and pharmaceutical preparations for treatment of inflammation and immunology disorders; biological and pharmaceutical preparations, namely, bi-specifics, multi specifics, T-cell engagers, radioligands and small molecules; Diagnostic preparations for medical purposes; biological and pharmaceutical preparations for treatment of cancer and tumors; human therapeutic vaccine preparations for use in oncology; anti-cancer preparations; therapeutic preparations being solutions, namely, antigens, antibodies, and antibody-drug conjugates; T-cells in the nature of preparations for treatment of cancer and tumors; diagnostic preparations for medical purposes, namely, antigens, antibodies, and cells for therapeutic use; medical preparations, namely, vaccines, antigens, and immunotherapeutic agents for the treatment and prevention of cancers and tumors
Scientific research services for medical purposes; scientific research services for medical purposes in the field of oncology; immunotherapy research; design and development of therapeutic vaccines, immunotherapy and pharmaceutical products; design and development of therapeutic products in oncology; research and development of antigenic and immunotherapeutic agents; research and development in the field of mRNA technology; research and development in the field of therapeutics; providing medical and scientific research information, namely, designing algorithms and models for use in scientific and medical research; providing temporary use of online non-downloadable computer software platforms featuring algorithms for analyzing cells, antigens, tissues, gene expressions, gene sequences, genome annotations, antigen characteristics and immunological responses; providing temporary use of an online non-downloadable computer software platform featuring algorithms for predicting the characteri...
